Provenance du réseau au premier degré de Julia Adam
Entité | Type d'entité | Industrie | |
---|---|---|---|
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Julia Adam via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Private Equity Analyst | |
MAXCYTE, INC. | Biotechnology | Director/Board Member | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Officer/Principal | |
IXICO PLC | Miscellaneous Commercial Services | Director/Board Member | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Analyst | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
The University of Nottingham | College/University | Doctorate Degree | |
University College Cork | College/University | Graduate Degree | |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Center for Strategic & International Studies, Inc.
Center for Strategic & International Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Molecular Vision Ltd.
Molecular Vision Ltd. Medical SpecialtiesHealth Technology Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom. | Medical Specialties | Director/Board Member | |
Chimeric Therapies, Inc. | Corporate Officer/Principal | ||
Ampika Ltd.
Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Drugstore Chains | Founder | |
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Touchstone Innovations Businesses LLP
Touchstone Innovations Businesses LLP Investment ManagersFinance Touchstone Innovations Businesses LLP commercializes academic research and technology businesses. The company was founded on December 19, 2007 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Maxwell School of Syracuse University | College/University | Graduate Degree | |
Reform Scotland Ltd.
Reform Scotland Ltd. Miscellaneous Commercial ServicesCommercial Services Reform Scotland Ltd. operates as a charity firm. It promotes economic prosperity and public services based on the principles of limited government, diversity and personal responsibility. The firm publishes Reports, Briefings Fact Sheets and Scottish Government Trackers. The company was founded in 2008 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ithaka Life Sciences Ltd.
Ithaka Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Ithaka Life Sciences Ltd. provides advisory, guidance, and support for the life science industry. The British company was founded by Paul Barton Rodgers, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
Inspiring Scotland
Inspiring Scotland Miscellaneous Commercial ServicesCommercial Services Inspiring Scotland engages in dealing and solving social problems for its people and communities. The company was founded by Helen Chambers in 2008 and is headquartered in Scotland, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Epidarex Capital Partners LLC
Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Founder Private Equity Investor | |
Topivert Pharma Ltd.
Topivert Pharma Ltd. Pharmaceuticals: MajorHealth Technology Topivert Pharma Ltd. is a British pharmaceutical company founded in 2011. The private company develops non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal. | Pharmaceuticals: Major | Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin | |
ProteinLogic Ltd.
ProteinLogic Ltd. Packaged SoftwareTechnology Services ProteinLogic Ltd. has developed a diagnostic technology platform called immiprint®, which detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. ProteinLogic is based in Cambridge, UK. These patterns form unique signatures of disease presence, stage, and potential response to treatment. The immiprint® technology has been clinically validated with the development of a signature in blood for the ruling out of active tuberculosis (TB), meeting the stringent criteria of the WHO for such a diagnostic test. The British company expects to create considerable additional value through the validation of other immiprint® signatures in its early stage development pipeline, with a focus on infectious, autoimmune, and inflammatory diseases. | Packaged Software | Chairman | |
Imperial College Business School | College/University | Masters Business Admin | |
SIRAKOSS Ltd.
SIRAKOSS Ltd. Medical SpecialtiesHealth Technology SIRAKOSS Ltd. develops medical devices. It focuses on synthetic Bone technology. The company was founded in October 2010 by Jordan Christopher Conway, Janet Mabel Scott Gibson, and Iain Ronald Gibson and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member | |
Caldan Therapeutics Ltd.
Caldan Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Kesios Therapeutics Ltd.
Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
Edinburgh Molecular Imaging Ltd.
Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
Adorx Therapeutics Ltd.
Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member | |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Macomics Ltd.
Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Investment Officer | |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Dunad Therapeutics Ltd. is a British biopharmaceutical company that specializes in developing targeted protein degradation therapies. Dunad was founded in 2020 and is headquartered in an undisclosed location, with operations in both the UK and the US. The company's platform allows for selective degradation through direct target modification using tuneable mono-valent small molecules, which enables the development of more drug-like, orally bioavailable, and CNS-accessible protein degraders. The company is backed by Epidarex Capital. Pearl Shirley Huang has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Kynos Therapeutics Ltd.
Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 36 |
Etats-Unis | 11 |
France | 4 |
Irlande | 2 |
Autriche | 2 |
Sectorielle
Health Technology | 26 |
Commercial Services | 9 |
Finance | 7 |
Consumer Services | 7 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 76 |
Corporate Officer/Principal | 18 |
Chairman | 15 |
Independent Dir/Board Member | 11 |
Founder | 10 |
Relations les plus connectées
Insiders | |
---|---|
Elaine Jones | 37 |
Maina Bhaman | 26 |
Andrew Dunlop | 18 |
Michael G. Moore | 16 |
Elizabeth Ann Roper | 16 |
Paul Barton Rodgers | 6 |
Miles Houslay | 1 |
Elizabeth Fairley | 1 |
David Adams | 1 |
Nigel Pyne | 1 |
Neil Wilkie | 1 |
- Bourse
- Insiders
- Julia Adam
- Connexions Sociétés